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ABBREVIATIONS
DRE Drug-resistant epilepsy
HRQoL Health-related quality of life
QOLCE Quality of Life in Childhood
Epilepsy
AIM To determine whether epilepsy surgery improved health-related quality of life (HRQoL)
and whether seizure freedom after surgery mediated the improvement in HRQoL.
METHOD This multicenter cohort study compared HRQoL after epilepsy surgery to
pharmacological management in children with drug-resistant epilepsy (DRE). HRQoL was
measured using the Quality of Life in Childhood Epilepsy (QOLCE) questionnaire at baseline
and 1-year follow-up. The mediator between treatment type and HRQoL was seizure
freedom.
RESULTS Two hundred and thirty-seven patients were recruited (surgery group: n=147 [92
males, 45 females]; pharmacological group: n=90 [53 males, 37 females]). Mean age at
seizure onset was 6 years (SD 4y 4mo) in the surgical group and 6 years 1 month (SD 4y) in
the pharmacological group. The odds ratio of seizure freedom was higher for the surgery
versus pharmacological group (b=4.24 [95% confidence interval {CI}: 2.26–7.93], p<0.001).
Surgery had no direct effect on total QOLCE score at 1-year (b=0.24 [95% CI –2.04 to 2.51],
p=0.839) compared to pharmacological management, but had an indirect effect on total
QOLCE that was mediated by seizure freedom (b=0.92 [95% CI 0.19–1.65], p=0.013), adjusting
for baseline total QOLCE score. Surgery had a direct effect on improving social function
(p=0.043), and an indirect effect on improving physical function (p=0.016), cognition
(p=0.042), social function (p=0.012) and behavior (p=0.032), mediated by seizure freedom.
INTERPRETATION Greater seizure freedom achieved through epilepsy surgery mediated the
improvement in HRQoL compared to pharmacological management in children with DRE.
1
Health-related quality of life (HRQoL) is defined by the
World Health Organization as a broad, multidimensional
construct that includes a person’s physical, psychological,
and social well-being. Children with epilepsy have impair-
ment in multiple domains of HRQoL, including higher
rates of behavioural, cognitive, emotional, social, and aca-
demic disorders, compared to typically developing children
or children with other chronic health conditions.1–5
HRQoL is considered to be a key patient-report outcome
by the Patient-Centered Outcomes Research Institute and
health regulatory agencies.6 Furthermore, HRQoL is
regarded as a key measure for evaluating treatment efficacy
by the International League Against Epilepsy.7
About 30% of patients with epilepsy have drug-resistant
epilepsy (DRE), defined as failure of adequate trials of two
tolerated and appropriate antiepileptic drugs.8 DRE can
have devastating consequences on children, including
impaired cognition,9 poor HRQoL,10,11 and 5 to 9 times’
increased mortality, relative to the general population.12,13
Further, patients with DRE consume disproportionately
more healthcare resources and have higher healthcare costs
compared to patients with well-controlled epilepsy.14
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Epilepsy surgery has been shown to improve seizure
control in children with DRE.15 The American Academy
of Neurology recommends epilepsy surgery for the treat-
ment of focal DRE.16 As epilepsy affects multiple facets of
the patients’ lives, the traditional method of evaluating the
success of epilepsy surgery, using a single clinical measure
of seizure control, is inadequate. Therefore, HRQoL,
which is multidimensional, is a highly appropriate patient-
centred construct for evaluating the effectiveness of epi-
lepsy surgery.
Existing studies exploring HRQoL in children after epi-
lepsy surgery are few, and frequently lack a control group
for comparison17–20 or do not measure baseline
HRQoL.20–23 Further, there are discrepant findings on
whether epilepsy surgery has a direct impact on HRQoL
relative to medical therapy, and which domains of HRQoL
improve with seizure freedom.15,23,24 The aims of this
study were to determine whether epilepsy surgery
improved HRQoL compared to pharmacological manage-
ment in children with DRE, and whether seizure freedom
mediated the improvement in HRQoL after treatment.
The hypothesis was that epilepsy surgery was more likely
to result in seizure-free outcome compared to pharmaco-
logical management and that seizure freedom mediated the
improvement in overall HRQoL and multiple domains of
HRQoL after epilepsy surgery.
METHOD
This multicenter, prospective cohort study recruited chil-
dren aged 4 to 18 years with focal DRE between 2010 and
2017. All children had suspected focal epilepsy as assessed
by clinical semiology and/or electroencephalography
(EEG) and were being evaluated for epilepsy surgery can-
didacy. Exclusion criteria included previous epilepsy sur-
gery, previous or planned palliative surgery (e.g. corpus
callosotomy) or vagus nerve stimulator placement, neu-
rometabolic disorders, neurodegenerative disorders, genetic
epilepsy syndromes, and epileptic encephalopathies (not
amenable to epilepsy surgery). All patients underwent
detailed epilepsy surgery evaluation including: clinical his-
tory, physical examination, magnetic resonance imaging,
video-EEG, and neuropsychological testing, supplemented
by additional neurodiagnostic tests as deemed necessary.
The decision to exclude a child from epilepsy surgery was
made as part of clinical care for a variety of reasons,
including inability to localize or lateralize a single epilepto-
genic focus and anticipated neurological deficits, such as
hemiplegia or language impairment, if surgery were to pro-
ceed. In this study, the medical group was defined as those
children with DRE who, after undergoing a standard diag-
nostic evaluation for epilepsy surgery candidacy, were
deemed ineligible for surgery. All patients were assessed at
baseline and at 1-year follow-up.
The study protocol was approved by the research ethics
board of the participating hospitals and written informed
consent and assent was obtained from parents and children
with epilepsy. We followed the Strengthening the
Reporting of Observational Studies in Epidemiology
(STROBE) guideline in this manuscript.
Clinical factors
Clinical data at baseline including age, sex, age at seizure
onset, seizure frequency, seizure type (temporal or extra-
temporal lobe), seizure laterality, and number of
antiepileptic drugs were obtained from the medical
records. The IQ of all patients was assessed using the
Wechsler Abbreviated Scale of Intelligence, Second
Edition (for ages 6–18y)25 or the Wechsler Preschool and




Seizure outcome at 1-year follow-up (1y after surgery in
the surgical group and 1y after study enrolment in the
pharmacological group) was assessed using the Interna-
tional League Against Epilepsy classification: Class 1, com-
pletely seizure-free; Class 2, only auras; Class 3, 1 to 3
seizure days per year; Class 4, 4 seizure days per year to
50% reduction in baseline number of seizure days; Class 5,
less than 50% reduction to 100% increase in baseline
number of seizure days; and Class 6, greater than 100%
increase in baseline number of seizure days. Seizure control
was then categorized as seizure free or persistent seizures
for subsequent analysis.
HRQoL
HRQoL was measured using the Quality of Life in Child-
hood Epilepsy (QOLCE) questionnaire.27 The QOLCE is
a 76-item parent-rated instrument covering five domains
(physical function, cognition, well-being, social function,
and behavior) and 16 subscales. The total QOLCE score is
the unweighted average of the 16 subscales, ranging from
0 to 100. Higher scores indicate better HRQoL. This
instrument has been reported to have good validity and
reliability.27,28 QOLCE scores were recorded at baseline
and at 1-year follow-up.
Statistical analysis
IBM SPSS version 23.0 (IBM Corporation, Armonk, NY,
USA) was used for statistical analysis. All variables were
screened for missing data and Little’s Missing Completely
at Random test was performed. The percentage of missing
values for age at seizure onset and IQ were 1.7% and
6.3% respectively. There were no missing data for the
other variables. Little’s Missing Completely at Random
What this paper adds
• Seizure freedom is higher after pediatric epilepsy surgery compared to phar-
macologically managed epilepsy.
• Surgery indirectly improves health-related quality of life (HRQoL) mediated
by seizure freedom compared to pharmacological management.
• Surgery has a direct effect on improving social function relative to pharma-
cological management.
• Baseline HRQoL was an important predictor of HRQoL after treatment.
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test showed that data were missing completely at random
(v2=0 [df=44], p=1.00). Subsequently, the fully conditional
specification multiple imputation method (five imputations)
was implemented. Pooled estimates of the five imputations
were reported. Appropriate tests of significance (t-test or
v2 test) were used to compare the means and proportions
of the baseline clinical variables and baseline QOLCE
scores for surgery and pharmacological management
groups.
The baseline characteristics of children who were seizure
free (irrespective of treatment) were compared to those
with persistent seizures. A multivariable logistic regression
model was used to predict seizure-free outcome. The inde-
pendent variables included treatment, age, sex, age at sei-
zure onset, number of antiepileptic drugs at baseline,
seizure type, and IQ. Clinical variables that influenced sei-
zure-free outcome were included in the mediation analysis.
The changes in total and domain QOLCE scores from
baseline to 1-year were compared for the surgical and
pharmacological groups using t-tests. Subsequently, a stan-
dard error of measurement-based criterion was used to
define children with clinically meaningful changes in
HRQoL from baseline to 1-year. When employing psy-
chometrically robust measures of HRQoL, scores of at
least 1 standard error of measurement are considered to
represent a clinically important intraindividual change in
HRQoL.29
A linear regression model was used to assess if seizure-
free status predicted total QOLCE score at 1-year follow-
up in the whole population, adjusting for baseline QOLCE
score. Another linear regression model was conducted to
assess if treatment predicted total QOLCE score at 1-year
follow-up in all seizure-free patients, adjusting for baseline
QOLCE score. A p-value of less than 0.05 was considered
statistically significant.
Mediation analysis
Mediation analysis30 was done within a structural equa-
tion framework using Mplus version 8.1 (Muthen and
Muthen, Los Angeles, CA, USA). We used maximum like-
lihood with robust estimation to evaluate if seizure-free
outcome mediated the relationship between treatment (sur-
gery vs pharmacological management) and total QOLCE
score at 1-year follow-up, adjusting for baseline total
QOLCE score. Both the direct and indirect effects of
treatment on total QOLCE score at 1-year were measured.
Subsequently, we evaluated if seizure-free outcome medi-
ated the relationship between treatment and the five
domains of HRQoL at 1-year follow-up, adjusting for each
of the five baseline domains of HRQoL. Both the direct
and indirect effects of treatment on the five domains of
HRQoL at 1-year were measured. The adequacy of model
fit was evaluated using the following statistics: Bentler’s
Comparative Fit Index (where >0.900 is acceptable);
Tucker-Lewis Index (where >0.900 is acceptable); root
mean square error of approximation (where <0.08 is
acceptable). The v2 test was not used for decisions of
model fit as it is sensitive to sample size.
We conducted sensitivity analysis using a Bayesian anal-
ysis to determine whether seizure-free outcome mediated
the relationship between treatment and HRQoL (both
total and domains QOLCE scores) at 1-year follow-up,
adjusting for the relevant baseline HRQoL. Conventional
frequentist mediation analysis uses a normal approximation
method to construct the confidence interval, whereby the
standard error of the indirect effect is estimated by the
first-order or second-order Taylor expansion.31,32 Bayesian
analysis has the advantage of not imposing normality
assumptions on the estimate of indirect effect33 and does
not rely on large sample approximations.34
RESULTS
Baseline characteristics
Of the 237 children included in the study, 147 were in the
surgical group (92 males, 45 females) and 90 in the pharma-
cological group (53 males, 37 females). Mean age at seizure
onset was 6 years (standard deviation [SD] 4y 4mo) in the
surgical group and 6 years 1 month (SD 4y) in the pharma-
cological group (Table 1). The median number of antiepilep-
tic drugs was two (interquartile range: 1–2) in each group.
Overall, 153 children (64.6%) had daily or weekly seizures,
which was more common in the surgical group (74.2%) than
in the pharmacological group (48.9%). Temporal epilepsy
was more common in the surgical group (40.1%) and extra-
temporal epilepsy was more common in the pharmacological
group (73.3%).
The baseline mean total QOLCE score was higher in
the surgical group (60.7 [95% CI 58.6–62.8]) than the
pharmacological group (56.6 [95% CI 53.7–59.4]). Physical
function and cognition were also higher in the surgical
group (Table 1, Fig. 1). The baseline total QOLCE score
had a Cronbach’s alpha of 0.962.
Seizure-free outcome at 1-year
The rate of seizure freedom at 1-year follow-up was signif-
icantly higher in the surgical group (88/147 [59.9%]) com-
pared to the pharmacological group (28/90 [31.1%])
(p<0.001). International League Against Epilepsy seizure
outcomes for the two groups are summarized in Table S1
(online supporting information). The baseline characteris-
tics of children who were seizure-free were similar to those
with persistent seizures in the pharmacological group
(Table S2, online supporting information).
Multivariable logistic regression showed that surgery was
associated with seizure-free outcome more frequently than
pharmacological management (odds ratio=4.24 [95% CI
2.26–7.93], p<0.001) (Table S3, online supporting informa-
tion). Age, sex, age at seizure onset, seizure type (temporal
vs extra-temporal), number of antiepileptic drugs, and IQ
at baseline did not predict seizure freedom (all p>0.05).
Hence, these variables were not included in the mediation
analysis.
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Histology in the surgical group included cortical malfor-
mations (n=49 patients), tuberous sclerosis (n=6), tumors
(n=27), mesial temporal sclerosis (n=15), gliosis (n=36), and
others (n=14) (Table S4, online supporting information).
Change in QOLCE scores
In the surgical group, the mean total QOLCE scores at
baseline and 1-year follow-up were 60.7 (95% CI 58.6–
62.8) and 63.2 (95% CI 61.2–65.1) respectively (p=0.001).
Physical function, social function, and behavior at 1-year
were significantly higher compared to baseline (p<0.05),
but there were no significant differences in cognition and
well-being at 1-year relative to baseline (p>0.05) (Table 2,
Fig. 1).
In the pharmacological group, the mean total QOLCE
scores at baseline and 1-year follow-up were 56.6 (95%
CI 53.7–59.4) and 59.0 (95% CI 56.1–62.0) respectively
(p=0.010). Physical function and behavior at 1-year were
significantly higher compared to baseline (p<0.05), but
cognition, well-being, and social function were not sig-
nificantly improved at 1-year relative to baseline
(p>0.05).
Forty-nine (33.3%) children in the surgical group and
33 (36.7%) in the pharmacological group showed clinically
meaningful increases (>1 standard error of measurement)
in total QOLCE score (p=0.60) (Table S5, online support-
ing information).
Seizure freedom (b=3.26 [95% CI 1.1–5.40], p=0.003)
was associated with higher total QOLCE score at 1-year
follow-up, when baseline total QOLCE score was included
as a covariate (b=0.72 [95% CI 0.64–0.81], p<0.001) in the
whole sample. In the subgroup who were seizure-free
(n=116), treatment (pharmacological or surgical) (b=1.50
[95% CI –1.68 to 4.69], p=0.35) was not associated with a
higher total QOLCE score at 1-year follow-up, when base-
line total QOLCE score was included as a covariate
(b=0.73 [95% CI 0.62–0.84], p<0.001).
Mediation analysis
The model fit for mediation analysis of seizure freedom on
the relationship between treatment type and QOLCE
scores (total and domain QOLCE scores) was adequate
(Table S6, online supporting information).
Total QOLCE score
Treatment type (surgery vs pharmacological management)
did not directly affect total QOLCE score at 1-year fol-
low-up (b=0.24 [95% CI –2.04 to 2.51], p=0.839) (Fig. 2,
Table 3). Seizure freedom (b=3.20 [95% CI 1.03–5.36],
p=0.004) and baseline total QOLCE score (b =0.72 [95%
CI 0.65–0.80], p<0.001) were significantly associated with
total QOLCE score at 1-year follow-up. Surgery was asso-
ciated with a seizure-free outcome more frequently than
pharmacological management (b=0.29 [95% CI 0.16–0.41],
p<0.001).
There was a significant indirect effect of surgery relative
to pharmacological management on improving total
QOLCE score at 1-year, through improved seizure free-
dom (b=0.92 [95% CI 0.19–1.65], p=0.013), adjusting for
baseline total QOLCE score.
Table 1: Baseline characteristics of the study participants
Surgical (n=147) Pharmacological (n=90) p
Mean (SD) age at enrolment, y:mo 11:8 (4:4) 10:9 (3:11) 0.06
Males/females, n 92/45 53/37 0.57
Mean (SD) age at seizure onset, y:mo 6:0 (4:4) 6:2 (4:0) 0.74
Antiepileptic drugs, median (IQR) 2 (1–2) 2 (1–2) 0.37
IQ, mean (SD) 85.41 (20.01) 87.13 (18.54) 0.51
Seizure frequency at baseline, n (%)
Daily/weekly 109 (74.15) 44 (48.89) 0.002
Monthly or less 38 (25.85) 46 (51.11)
Seizure laterality, n (%)
Left 77 (52.38) 36 (45) <0.001
Right 69 (46.94) 30 (37.5)
Bilateral 1 (0.68) 14 (17.5)
Seizure type, n (%)
Temporal 59 (40.14) 24 (26.67) 0.035
Extra-temporal 88 (59.86) 66 (73.33)
Type of surgery, n (%)
Lobectomy 54 (36.74)
Lesionectomy/tailored focal resection 52 (35.37)
Multi-lobar resection 35 (23.81)
Hemispherectomy 6 (4.08)
QOLCE score at baseline, mean (SD)
Physical 55.84 (17.99) 51.04 (16.93) 0.043
Social 52.19 (14.84) 48.93 (16.28) 0.116
Cognition 64.95 (20.11) 54.44 (21.39) <0.001
Well-being 69.23 (15.50) 69.34 (15.11) 0.826
Behavior 61.18 (13.52) 58.99 (13.46) 0.228
Total QOLCE score 60.68 (12.71) 56.55 (13.58) 0.019
Bold type indicates statistical significance. SD, standard deviation; IQR, interquartile range (Q3–Q1); QOLCE, Quality of Life in Childhood
Epilepsy.


























































































Figure 1: Box plots showing distribution of total Quality of Life in Childhood Epilepsy (QOLCE) score and five domains (physical, cognition, well-being,
social, and behaviour) scores at baseline and 1-year follow-up in both surgical and pharmacological groups. [Colour figure can be viewed at wileyon
linelibrary.com]
Table 2: Total Quality of Life in Childhood Epilepsy (QOLCE) and domain scores at baseline and 1-year for epilepsy surgery and pharmacological
management
Surgical group (n=147) Pharmacological group (n=90)
Baseline 1-year p Baseline 1-year p
Physical function 55.84 (52.91–58.77) 60.64 (57.74–63.54) <0.001 51.04 (47.49–54.59) 57.01 (52.84–61.18) <0.001
Cognition 64.95 (61.67–68.23) 64.38 (61.00–67.76) 0.696 54.44 (49.96–58.92) 56.29 (51.46–61.12) 0.207
Well-being 69.23 (66.70–71.76) 71.14 (68.67–73.61) 0.065 69.34 (66.17–72.51) 70.70 (67.68–73.72) 0.281
Social function 52.19 (49.77–54.61) 55.79 (53.82–57.76) 0.004 48.93 (45.52–52.34) 49.98 (46.87–53.09) 0.404
Behavior 61.18 (58.98–63.38) 63.81 (61.63–65.99) 0.003 58.99 (56.17–61.81) 61.09 (58.35–63.83) 0.031
Total QOLCE score 60.68 (58.61–62.75) 63.15 (61.21–65.09) 0.001 56.55 (53.71–59.29) 59.02 (56.08–61.96) 0.010
Data are mean (95% confidence interval).
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Domains of QOLCE
Surgery had a direct effect on improving social function
relative to pharmacological management (b=3.13 [95% CI
0.10–6.16], p=0.043) (Table 3). However, treatment type
(surgery vs pharmacological management) had no direct
effect on physical function, well-being, cognition, or
behavior (all p>0.05). Seizure freedom was associated with
improved physical function (b=5.51 [95% CI 1.67–9.36],
p=0.005), cognition (b=4.72 [95% CI 0.60–8.84], p=0.025),
social function (b=4.67 [95% CI 1.61–7.73], p=0.003), and
behavior (b=2.95 [95% CI 0.56–5.35], p=0.016), but not
with well-being (b=0.89 [95% CI 1.94–3.72], p=0.538) at
1-year follow-up. Physical function, well-being, cognition,
social function, and behavior at baseline predicted the cor-
responding domains at 1-year follow-up (all p<0.001).
Surgery had a significant indirect effect on improving
physical function (b=1.59 [95% CI 0.30–2.88], p=0.016),
cognition (b=1.36 [95% CI 0.05–2.67], p=0.042), social
function (b=1.34 [95% CI 0.30–2.39], p=0.012), and behav-
ior (b=0.85 [95% CI 0.07–1.63], p=0.032), which was
mediated through seizure freedom, after adjusting for base-
line physical function, cognition, social function, and
behavior respectively. However, there was no significant
indirect effect of treatment type on improving well-being
(b=0.26 [95% CI 0.5–1.07], p=0.541).
Sensitivity analysis
Bayesian analysis showed similar findings (Table S7, online
supporting information). There was no direct effect of
treatment type on total QOLCE score at 1-year. Seizure
freedom and higher baseline total QOLCE score were
associated with higher total QOLCE score at 1-year. Sur-
gery was associated with higher seizure-free outcome than
pharmacological management. Seizure freedom mediated
the relationship between surgery and higher total QOLCE
score at 1-year, adjusting for baseline total QOLCE score.
There was no direct effect of treatment type on physical
function, well-being, cognition, social function, and behav-
ior. Seizure freedom also mediated the relationship
between surgery and higher physical function, social func-
tion, and behavior, adjusting for baseline physical function,
social function, and behavior respectively.
DISCUSSION
This is the largest study assessing HRQoL in children with
DRE after epilepsy surgery compared to pharmacological
management. We used a structural equation framework to
tease out the direct and indirect effects of treatment on
HRQoL. We showed that treatment type did not have a
direct effect on overall HRQoL, but that seizure-free out-
come mediated the improvement in HRQoL after epilepsy
surgery. Our findings mirror other studies, which demon-
strated that children who were seizure-free after surgery
had higher HRQoL than those with persistent seizures.17–20,35
These studies compared the HRQoL amongst surgical
patients who were seizure-free relative to those who were
not, but did not include a pharmacological control group
or conduct a mediation analysis.
Our findings suggest that some, but not all, domains of
HRQoL improve with seizure freedom after surgery. In
our study, children who were seizure-free after surgery
showed improvements in most domains of HRQoL,
including physical function, cognition, social function, and
behavior, but not with well-being. Others also showed
improvement in physical function,17–20 cogni-
tion,17,18,20,21,36 and social function18–21,28 with seizure
freedom. However, there was lack of consensus with
respect to changes in behavior and well-being after surgery
amongst those who were seizure-free, with some reporting
no change in behaviour17,18 or well-being18,19,21 and others
reporting an improvement in behaviour19,22 or well-
being.20,36,37 Potential reasons for the lack of consensus in
findings could be related to small sample size,17,23 use of
variable HRQoL instruments, lack of a pharmacological
comparison group,17–20 or lack of presurgical baseline
HRQoL measurements.20–23
Seizure freedom
Total QOLCE score at 1y





Figure 2: The relationship between treatment (surgery vs pharmacologi-
cal management) and total Quality of Life in Childhood Epilepsy (QOLCE)
score at 1-year follow-up is mediated by seizure control, adjusting for
baseline total QOLCE score.
Table 3: Mediating effect of seizure freedom on the relationship between treatment (surgery vs pharmacological management) and health-related
quality of life (HRQoL)a at 1-year adjusting for baseline HRQoLa
Baseline score Seizure freedom Direct effect of treatment Indirect effect of treatment
Total QOLCE score 0.723 (0.648–0.799) 3.195 (1.033–5.358) 0.235 (–2.037 to 2.507) 0.919 (0.191–1.647)
Physical 0.609 (0.510–0.708) 5.513 (1.669–9.358) –0.877 (–4.871 to 3.117) 1.585 (0.296–2.875)
Cognition 0.668 (0.581–0.756) 4.719 (0.603–8.835) –0.291 (–4.457 to 3.875) 1.357 (0.047–2.666)
Well-being 0.583 (0.491–0.675) 0.889 (–1.940 to 3.718) 0.248 (–2.589 to 3.085) 0.256 (–0.563 to 1.074)
Social function 0.410 (0.317–0.504) 4.672 (1.614–7.730) 3.132 (0.099–6.164) 1.343 (0.300–2.387)
Behavior 0.628 (0.548–0.708) 2.954 (0.562–5.346) 0.499 (–1.870 to 2.867) 0.849 (0.071–1.627)
Data are b (95% confidence interval). aTotal Quality of Life in Childhood Epilepsy (QOLCE) and domain scores.
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There were discrepant findings in the literature as to
whether pediatric epilepsy surgery has a direct effect on
improving overall HRQoL. In a single-center randomized
controlled trial, Dwivedi et al.15 found an increase in total
HRQoL after surgery but not pharmacological manage-
ment, with a significant between-group difference. In their
study, surgery achieved a higher seizure-free rate, and
pharmacological therapy yielded a lower seizure-free rate,
relative to our cohort. The larger difference in seizure-free
outcome may have contributed to the higher overall
HRQoL in the surgical group relative to the pharmacolog-
ical group. Two other studies also found an increase in
overall HRQoL,38 physical activities,38 cognition,39 social
activities,38 and self-perceived competence39 in the surgical
group at follow-up compared to baseline, but these studies
did not include a pharmacological comparison group.
Mikati et al.23 did not identify an improvement in total
QOLCE score, general health, social function, cognition,
well-being, or physical function, but found an improve-
ment in behaviour in the surgical group compared to the
pharmacological group. In our study, we found that sur-
gery had a direct effect on improving social function com-
pared to pharmacological management, after adjusting for
baseline social function and seizure control. Differences in
findings could be related to patient populations and the
instruments used to assess HRQoL.
The proportion of seizure-free outcome amongst the
surgical and pharmacological groups in our study was
within the range reported in observational stud-
ies.21,23,36,40–45 We have included children with a variety of
pathologies and different types of seizures (temporal vs
extra-temporal), which reflects the ‘real-world’ phe-
nomenon of pediatric epilepsy surgery that is often charac-
terized by heterogeneous underlying etiology and seizure
location. Two meta-analyses, primarily from surgical
uncontrolled studies, showed that the seizure-free rate for
pediatric extra-temporal epilepsy (56%)46 was lower than
for temporal epilepsy (76%).47 We did not identify a dif-
ference in seizure-free outcome amongst those with tempo-
ral vs extra-temporal epilepsy. Other research also did not
identify a significant difference in seizure-free outcome
between temporal and extra-temporal epilepsy.48
An additional contribution of our study was in identify-
ing baseline HRQoL, both total and domains QOLCE
scores, as an important predictor of HRQoL at 1-year fol-
low-up, irrespective of treatment type. Sabaz et al.17 also
found that baseline HRQoL was a significant predictor of
change in HRQoL. This finding highlights the importance
of optimizing baseline HRQoL and represents a potential
target for future intervention.
Limitations of this study included a relatively short-term
(1y) follow-up after epilepsy surgery. Longer follow-up is
required to determine if the trajectory of HRQoL changes
over time after surgery, and whether domain(s) of HRQoL
that did not change at 1-year could change with longer fol-
low-up. However, in long-term follow-up studies of
patients with childhood-onset DRE, duration of follow-up
after surgery did not influence HRQoL.10,21 Second, we
did not consider other factors such as patient mood, care-
giver factors, and family function that could potentially
influence HRQoL after surgery. Patient mood, including
depression and anxiety, was previously shown to be an
important predictor of HRQoL after surgery.10,21 Family
variables such as fewer family resources, caregiver mood,
and caregiver unemployment were shown to be associated
with diminished HRQoL in children with DRE.11 The
contributions of caregiver and family factors on influencing
change in HRQoL after treatment represent a potential
area for future research. Third, we did not include children
with DRE below the age of 4 years, as there is no validated
instrument to measure HRQoL below this age. It is possi-
ble that younger children stand to benefit more from epi-
lepsy surgery, as recurrent seizures have a shorter duration
of impact on their development than older age at sur-
gery.41 Fourth, the control group comprised patients who
underwent epilepsy surgery evaluation and were considered
not suitable candidates for surgery due to inability to local-
ize the seizure focus. The selection of medical controls
based on their suitability for surgical treatment could have
confounded the findings. However, a previous randomized
controlled trial has demonstrated similar findings, in that
epilepsy surgery achieved a higher seizure-free and
HRQoL outcome than medical therapy.15 Other studies
on surgical outcomes have used the same strategy that we
used in the selection of a control group.10,40,44,49–51 These
studies, and our study, have demonstrated that the two
groups did not differ in their baseline characteristics
including age, sex, seizure-related clinical variables, and
cognitive and psychosocial function.
The present study provided strong evidence that greater
seizure freedom achieved through epilepsy surgery medi-
ated the improvement in HRQoL, in both overall and
multiple domains, compared to pharmacological manage-
ment in children with DRE. We also found that baseline
HRQoL was an important predictor of HRQoL after
treatment, emphasizing the importance of optimizing base-
line HRQoL to enhance improvement in HRQoL with
treatment.
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Table S4: Etiology of epilepsy in the surgical group
Table S5: Children with clinically meaningful changes in
health-related quality of life from baseline to 1-year based on
standard error of measurement
Table S6: Model fit for mediation analysis of seizure freedom
on the relationship between treatment type and Quality of Life in
Childhood Epilepsy scores
Table S7: Bayesian analysis to explore the mediating effect of
seizure freedom on the relationship between treatment and
health-related quality of life at 1-year
REFERENCES
1. Austin JK. Comparison of child adaptation to epilepsy
and asthma. J Child Adolesc Psychiatr Ment Health Nurs
1989; 2: 139–44.
2. Austin JK, Huster GA, Dunn DW, Risinger MW. Ado-
lescents with active or inactive epilepsy or asthma: a
comparison of quality of life. Epilepsia 1996; 37: 1228–
38.
3. Austin JK, Risinger MW, Beckett LA. Correlates of
behavior problems in children with epilepsy. Epilepsia
1992; 33: 1115–22.
4. Dunn DW, Austin JK, Huster GA. Symptoms of
depression in adolescents with epilepsy. J Am Acad
Child Adolesc Psychiatry 1999; 38: 1132–8.
5. Williams J, Steel C, Sharp GB, et al. Parental anxiety
and quality of life in children with epilepsy. Epilepsy
Behav 2003; 4: 483–6.
6. U.S. Department of Health and Human Services FDA
Center for Drug Evaluation and Research; U.S.
Department of Health and Human Services FDA Cen-
ter for Biologics Evaluation and Research; U.S. Depart-
ment of Health and Human Services FDA Center for
Devices and Radiological Health. Guidance for indus-
try: patient-reported outcome measures: use in medical
product development to support labeling claims: draft
guidance. Health Qual Life Outcomes 2006; 4: 79.
7. Thurman DJ, Beghi E, Begley CE, et al. Standards for
epidemiologic studies and surveillance of epilepsy.
Epilepsia 2011; 52(Suppl 7): 2–26.
8. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of
drug resistant epilepsy: consensus proposal by the ad
hoc Task Force of the ILAE Commission on Thera-
peutic Strategies. Epilepsia 2010; 51: 1069–77.
9. Hrabok M, Sherman EM, Bello-Espinosa L, Hader W.
Memory and health-related quality of life in severe
pediatric epilepsy. Pediatrics 2013; 131: e525–32.
10. Elliott I, Kadis DS, Lach L, et al. Quality of life in
young adults who underwent resective surgery for epi-
lepsy in childhood. Epilepsia 2012; 53: 1577–86.
11. Conway L, Smith ML, Ferro MA, et al. Correlates of
health-related quality of life in children with drug resis-
tant epilepsy. Epilepsia 2016; 57: 1256–64.
12. Berg AT, Shinnar S, Testa FM, Levy SR, Smith SN,
Beckerman B. Mortality in childhood-onset epilepsy.
Arch Pediatr Adolesc Med 2004; 158: 1147–52.
13. Camfield CS, Camfield PR, Veugelers PJ. Death in
children with epilepsy: a population-based study. Lancet
2002; 359: 1891–5.
14. Manjunath R, Paradis PE, Parise H, et al. Burden of
uncontrolled epilepsy in patients requiring an
emergency room visit or hospitalization. Neurology
2012; 79: 1908–16.
15. Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery
for drug-resistant epilepsy in children. N Engl J Med
2017; 377: 1639–47.
16. Engel J Jr, Wiebe S, French J, et al. Practice parameter:
temporal lobe and localized neocortical resections for
epilepsy: report of the Quality Standards Subcommittee
of the American Academy of Neurology, in association
with the American Epilepsy Society and the American
Association of Neurological Surgeons. Neurology 2003;
60: 538–47.
17. Sabaz M, Lawson JA, Cairns DR, et al. The impact of
epilepsy surgery on quality of life in children. Neurology
2006; 66: 557–61.
18. Zupanc ML, Rubio EJ, Werner RR, et al. Epilepsy sur-
gery outcomes: quality of life and seizure control. Pedi-
atr Neurol 2010; 42: 12–20.
19. Conway L, Widjaja E, Smith ML. Impact of resective
epilepsy surgery on health-related quality of life in chil-
dren with and without low intellectual ability. Epilepsy
Behav 2018; 83: 131–6.
20. Keene DL, Higgins MJ, Ventureyra EC. Outcome and
life prospects after surgical management of medically
intractable epilepsy in patients under 18 years of age.
Childs Nerv Syst 1997; 13: 530–5.
21. Puka K, Smith ML. Predictors of long-term quality of life
after pediatric epilepsy surgery.Epilepsia 2015; 56: 873–81.
22. Puka K, Smith ML. Long-term outcomes of behavior
problems after epilepsy surgery in childhood. J Neurol
2016; 263: 991–1000.
23. Mikati MA, Rahi AC, Shamseddine A, Mroueh S,
Shoeib H, Comair Y. Marked benefits in physical activ-
ity and well-being, but not in functioning domains, 2
years after successful epilepsy surgery in children. Epi-
lepsy Behav 2008; 12: 145–9.
24. Griffiths SY, Sherman EM, Slick DJ, Eyrl K, Connolly
MB, Steinbok P. Postsurgical health-related quality of
life (HRQoL) in children following hemispherectomy
for intractable epilepsy. Epilepsia 2007; 48: 564–70.
25. Wechsler D. Wechsler Abbreviated Scale of Intelli-
gence (WASI) manual. San Antonio, TX: The Psycho-
logical Corporation, 2011.
26. Wechsler D. Technical and Interpretive Manual for the
Wechsler Preschool and Primary Scale of Intelligence. San
Antonio, TX: The Psychological Corporation, 2012.
27. Sabaz M, Cairns DR, Lawson JA, Nheu N, Bleasel AF,
Bye AM. Validation of a new quality of life measure for
children with epilepsy. Epilepsia 2000; 41: 765–74.
28. Sabaz M, Lawson JA, Cairns DR, et al. Validation of the
quality of life in childhood epilepsy questionnaire in Ameri-
can epilepsy patients.Epilepsy Behav 2003; 4: 680–91.
29. Wyrwich KW, Tierney WM, Wolinsky FD. Further
evidence supporting an SEM-based criterion for identi-
fying meaningful intra-individual changes in health-re-
lated quality of life. J Clin Epidemiol 1999; 52: 861–3.
30. MacKinnon DP. Introduction to Statistical Mediation
Analysis. New York, NY: Taylor & Francis Group/
Lawrence Erlbaum Associates, 2008.
31. Aroian L. The probability function of the product of
two normally distributed variables. Ann Math Stat 1947;
18: 265–71.
32. Sobel M. Asymptotic confidence intervals for indirect
effects in structural equation models. In: Leinhardt S,
editor. Sociological Methodology. Washington, DC:
American Sociological Association, 1982: 290–312.
33. Yuan Y, MacKinnon DP. Bayesian mediation analysis.
Psychol Methods 2009; 14: 301–22.
34. Robert C. The Bayesian Choice: From Decision-theo-
retic Foundations to Computational Implementation,
2nd ed. New York, NY: Springer Verlag, 2007.
35. Dagar A, Chandra PS, Chaudhary K, et al. Epilepsy
surgery in a pediatric population: a retrospective study
of 129 children from a tertiary care hospital in a devel-
oping country along with assessment of quality of life.
Pediatr Neurosurg 2011; 47: 186–93.
36. Sibilia V, Barba C, Metitieri T, et al. Cognitive out-
come after epilepsy surgery in children: a controlled
longitudinal study. Epilepsy Behav 2017; 73: 23–30.
37. Tavares TP, Puka K, Smith ML. Emotional function-
ing: Long-term outcomes after pediatric epilepsy sur-
gery. Epilepsia 2015; 56: 745–53.
38. Titus JB, Lee A, Kasasbeh A, et al. Health-related qual-
ity of life before and after pediatric epilepsy surgery:
the influence of seizure outcome on changes in physical
functioning and social functioning. Epilepsy Behav 2013;
27: 477–83.
39. van Empelen R, Jennekens-Schinkel A, van Rijen PC,
Helders PJ, van Nieuwenhuizen O. Health-related
quality of life and self-perceived competence of children
assessed before and up to two years after epilepsy sur-
gery. Epilepsia 2005; 46: 258–71.
40. Edelvik A, Rydenhag B, Olsson I, et al. Long-term out-
comes of epilepsy surgery in Sweden: a national
prospective and longitudinal study. Neurology 2013; 81:
1244–51.
41. Otsuki T, Kim HD, Luan G, et al. Surgical versus
medical treatment for children with epileptic
Pediatric Epilepsy Surgery and HRQoL Puneet Jain et al. 607
encephalopathy in infancy and early childhood: Results
of an international multicenter cohort study in Far-East
Asia (the FACE study). Brain Dev 2016; 38: 449–60.
42. Oldham MS, Horn PS, Tsevat J, Standridge S. Costs
and clinical outcomes of epilepsy surgery in children
with drug-resistant epilepsy. Pediatr Neurol 2015; 53:
216–20.
43. Sinclair DB, Aronyk K, Snyder T, et al. Extratemporal
resection for childhood epilepsy. Pediatr Neurol 2004;
30: 177–85.
44. Skirrow C, Cross JH, Cormack F, Harkness W, Var-
gha-Khadem F, Baldeweg T. Long-term intellectual
outcome after temporal lobe surgery in childhood. Neu-
rology 2011; 76: 1330–7.
45. Teutonico F, Mai R, Devinsky O, et al. Epilepsy sur-
gery in tuberous sclerosis complex: early predictive ele-
ments and outcome. Childs Nerv Syst 2008; 24: 1437–
45.
46. Englot DJ, Breshears JD, Sun PP, Chang EF, Auguste
KI. Seizure outcomes after resective surgery for extra-
temporal lobe epilepsy in pediatric patients. J Neurosurg
Pediatr 2013; 12: 126–33.
47. Englot DJ, Rolston JD, Wang DD, Sun PP, Chang
EF, Auguste KI. Seizure outcomes after temporal
lobectomy in pediatric patients. J Neurosurg Pediatr
2013; 12: 134–41.
48. Rubinger L, Chan C, D’Arco F, et al. Change in
presurgical diagnostic imaging evaluation affects subse-
quent pediatric epilepsy surgery outcome. Epilepsia
2016; 57: 32–40.
49. Mikati MA, Ataya N, Ferzli J, et al. Quality of life after
surgery for intractable partial epilepsy in children: a
cohort study with controls. Epilepsy Res 2010; 90: 207–
13.
50. Markand ON, Salanova V, Whelihan E, Emsley CL.
Health-related quality of life outcome in medically
refractory epilepsy treated with anterior temporal lobec-
tomy. Epilepsia 2000; 41: 749–59.
51. Smith ML, Elliott IM, Lach L. Cognitive skills in
children with intractable epilepsy: comparison of sur-
gical and nonsurgical candidates. Epilepsia 2002; 43:
631–7.
608 Developmental Medicine & Child Neurology 2020, 62: 600–608
DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY ORIGINAL ARTICLE
RESUMEN
La ausencia de crises epilepticas en ni~nos mejora la calidad de vida relacionada con la salud despues de la cirugıa de epilepsia
OBJETIVO
Determinar si la cirugıa de epilepsia mejora la calidad de vida relacionada con la salud (HRQoL) y si la ausencia de crises epilepti-
cas despues de la cirugıa intervino en la mejora.
METODO
Estudio de cohorte, multicentrico que evaluo la HRQoL despues de la cirugıa de epilepsia comparandolo con el manejo farma-
cologico, en ni~nos con epilepsia farmacorresistente (DRE). La HRQoL se midio utilizando el cuestionario de calidad de vida en la
infancia (QOLCE) al inicio y despues de un a~no de seguimiento. El mediador entre el tipo de tratamiento y HRQoL fue la ausencia
de crises epilepticas.
RESULTADOS
Se reclutaron 237 pacientes (grupo de cirugıa: n 147 [92 varones, 45 mujeres]; grupo farmacologico: n 90 [53 varones, 37 muje-
res]). La edad promedio al inicio de las crisis epilepticas fue de 6 a~nos (DE 4 a~nos 4 meses) en el grupo quirurgico y 6 a~nos 1 mes
(DE 4 a~nos) en el grupo farmacologico. La relacion de probabilidad de la ausencia de crises epilepticas fue mayor para el grupo
de cirugıa frente a farmacologico (b = 4,24 [intervalo de confianza (IC) 95 %: 2.26–7.93], p<0.001). La cirugıa no tiene ningun efecto
directo sobre la puntuacion total de QOLCE a 1 a~no (b = 0,24 [IC del 95% –2,04 a 2,51], p=0,839) en comparacion con el tratamiento
farmacologico, pero tiene un efecto indirecto en el QOLCE total que fue mediado por la ausencia de crises epilepticas (b = 0,92 [IC
del 95% 0,19–1,65], p=0,013), ajustando la puntuacion total de QOLCE. La cirugıa tuvo un efecto directo en la mejora de la funcion
social (p=0.043), y un efecto indirecto en la mejora de la funcion fısica (p=0.016), la cognicion (p=0,042), la funcion social (p=0.012)
y el comportamiento (p=0.032), mediado por la ausencia de crises epilepticas.
INTERPRETACION
En este estudio encontramos que en ni~nos con DRE la ausencia mas significativa de crises epilepticas, lograda a traves de la cir-
ugıa de epilepsia, mediaba una mejor HRQoL en comparacion con el manejo farmacologico.
RESUMO
Ficar sem crises epilepticas melhora a qualidade de vida relacionada a saude apos cirurgia para epilepsia em criancas
OBJETIVO
Determinar se a cirurgia para epilepsia melhora a qualidade de vida relacionada a saude (QVRS) e se ficar sem crises epilepticas
apos a cirurgia media a melhora na QVRS.
METODO
Este estudo de coorte multicêntrico comparou a QVRS apos cirurgia para epilepsia ao manejo farmacologico em criancas com epi-
lepsia resistente a drogas (ERD). A QVRS foi medida usando o questionario Qualidade de Vida na Epilepsia Infantil (QVEI) na linha
de base e no acompanhamento apos 1 ano. O mediador entre o tipo de tratamento e a QVRS foi estar sem crises epilepticas.
RESULTADOS
Duzentos e trinta e sete pacientes foram recrutados (grupo cirurgia: n=147 [92 do sexo masculino, 45 do sexo feminino]; grupo far-
macologico: n=90 [53 do sexo masculino, 37 do sexo feminino]). A media de idade no inıcio das crises foi 6 anos (DP 4a 4m) no
grupo cirurgico e 6 anos e 1 mês (DP 4a) no grupo farmacologico. A taxa de risco de estar sem crises foi maior no grupo cirurgia
versus farmacologico (b=4,24 [intervalo de confianca a 95% {IC}: 2,26–7,93], p<0,001). A cirurgia n~ao teve efeito direto no QVEI total
apos 1 ano (b=0,24 [IC 95% –2,04 a 2,51], p=0,839) comparada ao manejo farmacologico, mas teve efeito indireto no QVEI total
que foi medido pelo fato de estar livre de crises (b=0,92 [IC 95% 0,19–1,65], p=0,013), ajustando para o escore total QVEI na linha
de base. A cirurgia teve efeito direto na melhora da func~ao social (p=0,043), e efeito indireto na melhora da func~ao fısica
(p=0,016), cognic~ao (p=0,042), func~ao social (p=0.012) comportamento (p=0,032), mediada pelo fato de estar sem crises.
INTERPRETAC~AO
A maior chance de ficar sem crises, atingida por meio da cirurgia, mediou a melhora na QVRS em comparac~ao com o manejo far-
macologico em criancas com ERD.
